Cambridge Investment Research Advisors, Inc. Exact Sciences Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 42,628 shares of EXAS stock, worth $2.39 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
42,628
Previous 42,979
0.82%
Holding current value
$2.39 Million
Previous $1.82 Million
59.91%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding EXAS
# of Institutions
667Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$994 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$887 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$802 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$675 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$374 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.91B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...